If you're on semaglutide and thinking about a baby, the short answer is this: most guidance is to stop at least about 2 months (roughly 8 weeks) before you start trying to conceive. Semaglutide has a long half-life, about one week, so it needs time to fully clear your body first. GLP-1 medications are not recommended during pregnancy and are not fertility drugs. Plan the timing with your provider so you stop at the right point for you.
Key takeaways
- Stop about 2 months (≈8 weeks) before trying to conceive. This is the guidance in the FDA-approved label for semaglutide.
- Semaglutide's half-life is about one week, so it takes roughly five weeks to fully clear. The two-month window adds a safety buffer.
- GLP-1s aren't recommended in pregnancy and offer no benefit to a pregnant patient; they are not fertility medications.
- If you become pregnant while taking a GLP-1, stop it and call your provider promptly, but don't panic.
- Tirzepatide clears a little faster (half-life ~5 days) but follows the same "stop before conceiving" principle. Your provider sets your exact timeline.
How long before pregnancy should you stop semaglutide?
Plan to stop at least about 2 months before you begin trying to conceive. The FDA-approved prescribing information for semaglutide (sold as Wegovy) states that patients should "discontinue WEGOVY at least 2 months before a planned pregnancy because of the long half-life" of the drug.[1]
Two months can feel like a long lead time when you're eager to start. The reason is pharmacology, not caution for its own sake: semaglutide lingers in your system for weeks after your last dose, and the goal is to have it fully cleared before a pregnancy could begin.
It helps to separate two questions. How long until the drug is gone? is about clearance. When should I stop? builds in an extra margin on top of that, because you can't always predict the exact cycle you'll conceive.
The washout math
A drug's half-life is the time it takes for half of it to leave your body. It takes about five half-lives for a medication to be considered fully cleared. Here's how that plays out for the two most common GLP-1 molecules:
| Medication (brands) | Half-life | Approx. time to fully clear | Guidance before conceiving |
|---|---|---|---|
| Semaglutide (Wegovy, Ozempic) | ~1 week | ~5 weeks | Stop at least 2 months (≈8 weeks) before, per the Wegovy label[1] |
| Tirzepatide (Zepbound, Mounjaro) | ~5 days | ~4 weeks | Stop before trying to conceive; many clinicians apply a similar ~2-month buffer as a precaution |
A note on names, because the labels differ: Wegovy and Zepbound are FDA-approved for chronic weight management, while Ozempic and Mounjaro are FDA-approved for type 2 diabetes and used off-label for weight loss. The washout logic is the same across them because it depends on the molecule, not the brand.
Do you need to stop tirzepatide before conceiving too?
Yes. Tirzepatide is also not recommended in pregnancy, so it should be stopped before you try to conceive. Its half-life is a bit shorter, roughly 5 days, per the FDA-approved Zepbound label, so it clears in about four weeks.[2] Even so, many clinicians apply a similar precautionary buffer of about two months as a matter of clinical practice, and the Cleveland Clinic notes that a washout period between stopping a GLP-1 and getting pregnant is advised.[3]
There's a second, women-specific reason to loop in your provider early if you're on tirzepatide: it can lower the effectiveness of oral birth control for a window after starting and after each dose increase, something semaglutide doesn't do. If you're timing a pregnancy, that interaction matters both ways. We cover it in detail in why tirzepatide is different from semaglutide for birth control.
Why aren't GLP-1s used during pregnancy?
Because there isn't enough evidence that they're safe, and weight loss isn't a goal during pregnancy. The semaglutide label is direct: when a pregnancy is recognized, the medication should be discontinued, because weight loss "offers no benefit" to a pregnant patient and animal studies point to potential fetal risk.[1] The FDA has said it can't rule out a risk to a developing pregnancy for either semaglutide or tirzepatide.[1][2]
A related point that trips women up: GLP-1s are not fertility drugs, but they can still make pregnancy more likely. Losing weight and improving insulin sensitivity, especially with PCOS, can restore more regular ovulation, which is exactly why the "Ozempic babies" stories exist. If you weren't expecting to be fertile, you may be more fertile than you think. We unpack that in our guide to GLP-1s, fertility, and "Ozempic babies", and you can read more about how these medications change your cycle.
The usual safety basics still apply
Whatever your pregnancy plans, GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are contraindicated if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).[1][2] They also carry cautions for pancreatitis, gallbladder problems, and significant gastrointestinal side effects. None of this is a substitute for a conversation with a licensed provider about your history.
What if you get pregnant while taking semaglutide?
Stop the medication and contact your provider as soon as you can, but don't panic. The prescribing information directs that semaglutide be discontinued once a pregnancy is recognized.[1] Your clinician (and your OB) can talk through next steps and monitoring.
It's worth saying plainly: an unplanned pregnancy on a GLP-1 is not a reason for alarm or self-blame. Data in pregnant patients are limited, which is why the medications aren't recommended, not because there's proof of harm. The right move is simply to stop and get personalized guidance quickly, rather than trying to sort it out alone.
What about breastfeeding?
There isn't enough safety data, so GLP-1s are generally avoided while breastfeeding. There's no reliable information on whether semaglutide passes into human milk or how it might affect a nursing infant, and the manufacturer advises weighing the benefits of breastfeeding against the clinical need for the medication.[1] For semaglutide tablets, the label states breastfeeding "is not recommended."[1] The practical takeaway: talk to your provider about timing before you restart any GLP-1 postpartum.
How Elara helps
Timing a stop-and-conceive plan is exactly the kind of decision that shouldn't happen by guesswork. At Elara, a licensed provider reviews every patient, including your pregnancy plans, cycle history, birth control, and PCOS or thyroid history, and helps you map out when to pause and what to watch for.
Considering semaglutide? Elara's compounded semaglutide program starts at $247/month (about $198/month on the 12-month plan), all-inclusive: your provider visit, medication, shipping, ongoing support, and the Elara app. Cash-pay, no insurance runaround, available in all 50 states and Puerto Rico.
About compounded medications: Compounded semaglutide and tirzepatide are prepared by a
state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate for you.
**Compounded medications are not FDA-approved and are not reviewed by the FDA for safety,
effectiveness, or quality.** They are not "generic" versions of Ozempic®, Wegovy®, Mounjaro®, or
Zepbound®. Talk to a licensed clinician about whether a compounded or FDA-approved option is right for you.
Frequently asked questions
How long before pregnancy should you stop semaglutide?
Guidance is to stop at least about 2 months (≈8 weeks) before you start trying to conceive. That's what the FDA-approved semaglutide label recommends, because the drug has a long half-life of roughly one week and needs time to fully clear. Confirm the exact timing with your provider.
Do you stop tirzepatide before conceiving too?
Yes. Tirzepatide is also not recommended in pregnancy. Its half-life is shorter (about 5 days), so it clears in roughly four weeks, but many clinicians still apply a cautious buffer of about two months before conception. Tirzepatide can also reduce oral birth control effectiveness, so plan the timing with your provider.
What if I got pregnant while on semaglutide?
Stop the medication and contact your provider as soon as you can. The label directs discontinuing semaglutide once a pregnancy is recognized. Limited data is the reason GLP-1s aren't recommended in pregnancy, not proof of harm, so don't panic; get personalized guidance from your clinician and OB promptly.
Is semaglutide safe while breastfeeding?
There isn't enough data to call it safe, so GLP-1s are generally avoided while breastfeeding. It's unknown whether semaglutide passes into human milk, and the semaglutide tablet label states breastfeeding is not recommended. Talk to your provider about the right timing before restarting any GLP-1 after delivery.
How long does semaglutide stay in your system?
Semaglutide's half-life is about one week, and a drug is considered fully cleared after roughly five half-lives, so it takes about five weeks to leave your system after your last dose. The recommended two-month stop-before-pregnancy window builds an extra safety margin on top of that.
The bottom line
If you're planning a pregnancy, the practical rule is to stop semaglutide about 2 months before you try to conceive, because it takes several weeks to fully clear and the medications aren't recommended in pregnancy. Tirzepatide follows the same principle on a slightly shorter timeline. These aren't fertility drugs, but they can make pregnancy more likely, so plan the timing with a licensed provider rather than leaving it to chance.
This article is for general education and is not medical advice. It doesn't replace a conversation
with a licensed clinician about your health, medications, or treatment. Reading it doesn't create a
doctor-patient relationship. If you have a medical emergency, call 911. See our full
Medical Disclaimer.
References
- DailyMed. "WEGOVY (semaglutide) injection, Prescribing Information." U.S. National Library of Medicine (FDA label). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- DailyMed. "ZEPBOUND (tirzepatide) injection, Prescribing Information." U.S. National Library of Medicine (FDA label). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Cleveland Clinic. "'Ozempic Babies': How GLP-1 Agonists Affect Fertility." Cleveland Clinic Health Essentials. https://health.clevelandclinic.org/ozempic-babies